Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis

C Costa, JN Moreira, MH Amaral, JMS Lobo… - Journal of Controlled …, 2019‏ - Elsevier
Epileptic seizures and anxiety crisis are severe conditions that require fast and effective
treatment, targeting the brain. Current emergency antiepiletics and anxiolytics have limited …

Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system

A Mishra, R Kumar, J Mishra, K Dutta, P Ahlawat… - Journal of Drug Delivery …, 2023‏ - Elsevier
The blood-brain barrier (BBB) is a membrane barrier considered one of the most crucial
protective architectures in the central nervous system (CNS). Its presence acts as a hurdle …

[HTML][HTML] Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain

S Liu, S Yang, PC Ho - Asian journal of pharmaceutical sciences, 2018‏ - Elsevier
Epilepsy is considered as a common and diverse set of chronic neurological disorders and
its symptoms can be controlled by antiepileptic drugs (AEDs). The presence of p …

[HTML][HTML] Epilepsy disease and nose-to-brain delivery of polymeric nanoparticles: an overview

T Musumeci, A Bonaccorso, G Puglisi - Pharmaceutics, 2019‏ - mdpi.com
Epilepsy is the fourth most common global neurological problem, which can be considered a
spectrum disorder because of its various causes, seizure types, its ability to vary in severity …

A review of intranasal formulations for the treatment of seizure emergencies

M Kapoor, JC Cloyd, RA Siegel - Journal of Controlled Release, 2016‏ - Elsevier
Epileptic seizure emergencies are life-threatening conditions, which in their most severe
form, status epilepticus, have a high mortality rate if not quickly terminated. Treatment …

[HTML][HTML] Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation

M Yasir, UVS Sara - Acta Pharmaceutica Sinica B, 2014‏ - Elsevier
In the present study, haloperidol (HP)-loaded solid lipid nanoparticles (SLNs) were prepared
to enhance the uptake of HP to brain via intranasal (in) delivery. SLNs were prepared by a …

Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3

D Rufino-Ramos, PR Albuquerque, K Leandro… - Molecular Therapy, 2023‏ - cell.com
Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3) is the most common
autosomal dominantly inherited ataxia worldwide. It is caused by an over-repetition of the …

PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization

DE Igartúa, CS Martinez, CF Temprana… - International Journal of …, 2018‏ - Elsevier
Carbamazepine (CBZ) is an antiepileptic drug, which also could be used in the treatment of
neurodegenerative diseases, such as the Alzheimer's disease. However, its use has been …

Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study

MM Ibrahim, EB Basalious, MA El-Nabarawi… - Drug Delivery and …, 2024‏ - Springer
Mirtazapine (MZPc) is an antidepressant drug which is approved by the FDA. It has low
bioavailability, which is only 50%, in spite of its rapid absorption when orally administered …

Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: Formulation, optimization and in vivo characterization

AP Rajput, SB Butani - Journal of drug delivery science and technology, 2019‏ - Elsevier
The purpose of the present study was to formulate resveratrol loaded nanostructured lipid
carrier based in situ gel for intranasal administration. Resveratrol loaded lipid carrier was …